$CBAY News Article - Seladelpar Granted Revised Br
Post# of 51
(Total Views: 84)
Posted On: 10/23/2023 11:25:49 AM
$CBAY News Article - Seladelpar Granted Revised Breakthrough Therapy Designation for the Treatment of Primary Biliary Cholangitis Including Pruritus in Patients Without Cirrhosis or With Compensated Cirrhosis https://marketwirenews.com/news-releases/sela...27521.html
(0)
(0)CymaBay Therapeutics Inc. (CBAY) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼